Minimed Group

Minimed Group

Health Information Services
Minimed Group, Inc. is a healthcare technology company dedicated to improving the lives of individuals with diabetes through the design, manufacture, and sale of advanced medical devices. The company's primary focus is on insulin delivery systems, including wearable insulin pumps and related accessories, which are designed to provide more precise and user-friendly management of blood glucose levels. Operating within the Health Care Equipment industry, Minimed Group emphasizes the integration of hardware and software to create seamless diabetes care ecosystems. Their products target both Type 1 and Type 2 diabetes patients, focusing on enhancing clinical outcomes while reducing the daily burden of disease management. The company's technology often incorporates data connectivity and automated features, aligning with the industry trend toward 'smart' medical devices and automated insulin delivery (AID) systems. Minimed Group's strategic initiatives involve significant investment in research and development to maintain a pipeline of next-generation devices. By leveraging data analytics and patient-centric design, the company aims to capture market share in the global diabetes care sector, competing with other major medical device manufacturers by offering specialized, high-performance insulin delivery platforms.

$6.1B

Market Cap • 9/18/2026

2025

(1 year)

Founded

2050

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

1,7

P/S

1,9

P/EBITDA

P/OCF

P/FCF

P/E

BVPS

13,7

EPS

Market Cap

Market Cap

6,1B

EV

5,9B

EV/Revenue

1,8

EV/EBITDA

-423,1

EV/EBIT

-34,4

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-116M

Profitability

Gross Margin

53,9%

EBITDA Margin

EBIT Margin

Net Margin

D&A/EBITDA

0%

R&D/Revenue

13,6%

Capex/Revenue

6,5%

Capex/D&A

133,5%

Capex/OCF

-201%

SBC/OCF

% PPE

15,6%

% Goodwill

47,8%

ROE

ROIC

Leverage

N.D./EBITDA

14,8

Debt/Equity

0%

Current Ratio

1,8

Quick Ratio

1,3

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium